Bryan D. Beel

General

Please sign up or log in to access the advanced features of
Ex Parte Professional.

Experience10 yrs

Elite Ratings

DCT,

PTAB,

CAFC

Practice Areas

Communications (150 cases)

Biotech (140 cases)

Design (130 cases)

Law Firms

Please sign up or log in to access the advanced features of
Ex Parte Professional.

Experience

Grade

Trend

DCT

PTAB

CAFC

Please sign up or log in to access the advanced features of
Ex Parte Professional.

Case #	Court	Caption	Filed	Represent
1:00-CV-00001	D. NJ	Oyster Point Pharma Inc v. Apotex Inc	07/19/23	Patent Owner : Samsung Electronics Co Ltd
1:00-CV-00002	D. DE	Novo Nordisk Inc v. Mylan Pharma Inc	01/27/23	Challenger (L) : Apple Inc
1:00-CV-00003	D. DE	Novo Nordisk Inc v. Mylan Pharma Inc	08/08/22	Patent Owner : Google LLC
1:00-CV-00004	D. DE	Otsuka Pharmaceutical Co Ltd v. Mylan Laboratories Ltd	04/08/22	Challenger (W) : Microsoft Corp
1:00-CV-00005	D. NJ	Bristol Myers Squibb Co v. Xspray Pharma Ab	02/23/22	Patent Owner (L) : LG Electronics Inc
1:00-CV-00006	D. NJ	Pacira Pharma Inc v. Evenus Pharma Laboratories Inc	11/08/21	Challenger : Facebook Inc
1:00-CV-00007	D. DE	Novartis Pharma Corp v. Torrent Pharma Inc	09/20/21	Patent Owner (W) : Intel Corp
1:00-CV-00008	D. DE	AbbVie Inc v. DR Reddys Laboratories Ltd	07/21/20	Challenger (W) : Uniloc USA Inc
1:00-CV-00009	N.D. WV	Merck Sharp & Dohme BV v. Mylan Pharma Inc	04/02/20	Patent Owner : Sony Corp
1:00-CV-00010	D. NJ	Merck Sharp & Dohme BV v. Mylan API US LLC	03/25/20	Challenger (L) : Cisco Systems Inc